![Michael Weiss](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 377 M $ al 31/05/2026
El Sr. Michael S. Weiss es Presidente de Checkpoint Therapeutics, Inc., Presidente Ejecutivo de Mustang Bio, Inc., Socio de Opus Point Partners Management LLC, Socio y Gestor de Cartera de Opus Point Partners LLC y Presidente Ejecutivo, Presidente y Director General de TG Therapeutics, Inc. Es miembro del Consejo de Administración de Cyprium Therapeutics, Inc., Fortress Biotech, Inc., Caelum Biosciences, Inc., Cellvation, Inc. y Helocyte, Inc. El Sr. Weiss fue anteriormente presidente de National Holdings Corp, director no ejecutivo de Avenue Therapeutics, Inc, copresidente de CB Pharma Acquisition Corp, presidente ejecutivo de IASO Pharma, Inc, presidente no ejecutivo de National Holdings Corp, presidente de XTL Biopharmaceuticals Ltd., presidente y director general de Keryx Biopharmaceuticals, Inc., presidente y director general de ACCESS Oncology, Inc., presidente de Paligent, Inc., administrador de Cancer Care, Inc. y abogado de Cravath, Swaine & Moore LLP. También fue miembro del consejo de administración de Healthcare Integrated Services, Inc. y de Genta, Inc. Se licenció en la Universidad Estatal de Nueva York en Albany y se graduó en la Facultad de Derecho de Columbia.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
TG THERAPEUTICS, INC. 6,39 % | 14/04/2026 | 9.778.086 ( 6,39 % ) | 371 M $ | 31/05/2026 |
FORTRESS BIOTECH, INC. 6,85 % | 16/04/2026 | 2.276.562 ( 6,85 % ) | 6 M $ | 31/05/2026 |
| 18/11/2025 | 325 ( 0 % ) | 218 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| TG THERAPEUTICS, INC. | Director Ejecutivo | 29/12/2011 |
| FORTRESS BIOTECH, INC. | Director/Miembro de la Junta | 20/12/2013 |
| MUSTANG BIO, INC. | Presidente | 01/05/2015 |
Cyprium Therapeutics, Inc.
 Cyprium Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel therapies for the treatment of menkes disease and related copper metabolism disorders | Fundador | 01/01/2017 |
Cellvation, Inc.
 Cellvation, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel cellular therapeutics for treatment of traumatic brain injury | Director/Miembro de la Junta | - |
Helocyte, Inc.
 Helocyte, Inc. BiotechnologyHealth Technology Operates as a clinical stage company that develops novel immunotherapies for the prevention and treatment of cancer and infectious disease | Director/Miembro de la Junta | - |
Baergic Bio, Inc.
 Baergic Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs for treatment of central nervous system disorders | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
| CHECKPOINT THERAPEUTICS, INC. | Director Ejecutivo | 01/12/2016 |
| AVENUE THERAPEUTICS, INC. | Director/Miembro de la Junta | 08/02/2019 |
| ░░░░ ░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 25 |
|---|---|
Paligent, Inc.
 Paligent, Inc. Financial ConglomeratesFinance Development stage company | Finance |
TG Therapeutics, Inc.
 TG Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
National Holdings Corp.
 National Holdings Corp. Investment Banks/BrokersFinance Operates as a holding company whose subsidiaries provides securities brokerage services | Finance |
Healthcare Integrated Services, Inc.
 Healthcare Integrated Services, Inc. Medical/Nursing ServicesHealth Services Operates fixed-site magnetic resonance imaging centers | Health Services |
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
ACCESS Oncology, Inc.
 ACCESS Oncology, Inc. Pharmaceuticals: OtherHealth Technology Develops pharmaceutical drugs | Health Technology |
Genta, Inc.
 Genta, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical research and development | Health Technology |
IASO Pharma, Inc.
 IASO Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutic products | Health Technology |
Fortress Biotech, Inc.
 Fortress Biotech, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical and biotechnology products | Health Technology |
XTL Biopharmaceuticals Ltd.
 XTL Biopharmaceuticals Ltd. Medical SpecialtiesHealth Technology Develops pharmaceutical drugs for the treatment of autoimmune diseases | Health Technology |
Cravath, Swaine & Moore LLP
 Cravath, Swaine & Moore LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
State University of New York at Albany
 State University of New York at Albany Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cancer Care, Inc.
 Cancer Care, Inc. Hospital/Nursing ManagementHealth Services Provides cancer treatment services | Health Services |
Opus Point Partners Management LLC
 Opus Point Partners Management LLC Investment ManagersFinance OPPM invests in and assists biotechnology and healthcare companies in developing and commercializing novel medicines and diagnostic tools. | Finance |
Columbia Law School
 Columbia Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Origo Acquisition Corp.
 Origo Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Checkpoint Therapeutics, Inc.
 Checkpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Opus Point Partners LLC
 Opus Point Partners LLC Financial ConglomeratesFinance Provides investment services | Finance |
Avenue Therapeutics, Inc.
 Avenue Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops and commercializes therapies for neurological diseases | Health Technology |
Helocyte, Inc.
Helocyte, Inc. BiotechnologyHealth Technology Operates as a clinical stage company that develops novel immunotherapies for the prevention and treatment of cancer and infectious disease | Health Technology |
Mustang Bio, Inc.
 Mustang Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops novel immunotherapy''s | Health Technology |
Cyprium Therapeutics, Inc.
Cyprium Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel therapies for the treatment of menkes disease and related copper metabolism disorders | Health Technology |
Cellvation, Inc.
Cellvation, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel cellular therapeutics for treatment of traumatic brain injury | Health Technology |
Caelum Biosciences, Inc.
 Caelum Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that develops treatments for AL amyloidosis, rare and life-threatening hematologic disorders | Health Technology |
Baergic Bio, Inc.
Baergic Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs for treatment of central nervous system disorders | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
